Zhi Xiong Chong

Dr. Zhi Xiong Chong

University of Nottingham Malaysia
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2021 in PeerJ
Verified
Journal Article
Open access
PDF file
ZCZhi Xiong Chong
Zhi Xiong Chong
SYSwee Keong Yeap
Swee Keong Yeap
WHWan Yong Ho
Wan Yong Ho
Transfection is a modern and powerful method used to insert foreign nucleic acids into eukaryotic cells. The ability to modify host cells’ genetic content enables the broad application of this process in studying normal cellular processes, disease molecular mechanism and gene therapeutic effect. In this review, we summarized and compared the findings from various reported literature on the characteristics, strengths, and limitations of various transfection methods, type of transfected nucleic acids, transfection controls and approaches to assess transfection efficiency. With the vast choices of approaches available, we hope that this review will help researchers, especially those new to the field, in their decision making over the transfection protocol or strategy appropriate for their experimental aims.

1 October 2021 in Pharmacological Research
Verified
Journal Article
Closed access
ZCZhi Xiong Chong
Zhi Xiong Chong
SYSwee Keong Yeap
Swee Keong Yeap
WHWan Yong Ho
Wan Yong Ho

25 March 2021 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
ZCZhi Xiong Chong
Zhi Xiong Chong
SYSwee Keong Yeap
Swee Keong Yeap
WHWan Yong Ho
Wan Yong Ho
Breast cancer is the most common solid cancer that affects female population globally. MicroRNAs (miRNAs) are short non-coding RNAs that can regulate post-transcriptional modification of multiple downstream genes. Autophagy is a conserved cellular catabolic activity that aims to provide nutrients and degrade un-usable macromolecules in mammalian cells. A number of in vitro, in vivo and clinical studies have reported that some miRNAs could modulate autophagy activity in human breast cancer cells, and these would influence human breast cancer progression and treatment response. Therefore, this review was aimed to discuss the roles of autophagy-regulating miRNAs in influencing breast cancer development and treatment response. The review would first introduce autophagy types and process, followed by the discussion of the roles of different miRNAs in modulating autophagy in human breast cancer, and to explore how would this miRNA-autophagy regulatory process affect the disease progression or treatment response. Lastly, the potential applications and challenges of utilizing autophagy-regulating miRNAs as breast cancer biomarkers and novel therapeutic agents would be discussed.

Verified
Journal Article
Open access
PDF file
LLLloyd Ling
Lloyd Ling
AAAhmed Faris Aldoghachi
Ahmed Faris Aldoghachi
ZCZhi Xiong Chong
Zhi Xiong Chong
WHWan Yong Ho
Wan Yong Ho
SYSwee Keong Yeap
Swee Keong Yeap
HOHan Kiat Ong
Han Kiat Ong
Detecting breast cancer (BC) at the initial stages of progression has always been regarded as a lifesaving intervention. With modern technology, extensive studies have unraveled the complexity of BC, but the current standard practice of early breast cancer screening and clinical management of cancer progression is still heavily dependent on tissue biopsies, which are invasive and limited in capturing definitive cancer signatures for more comprehensive applications to improve outcomes in BC care and treatments. In recent years, reviews and studies have shown that liquid biopsies in the form of blood, containing free circulating and exosomal microRNAs (miRNAs), have become increasingly evident as a potential minimally invasive alternative to tissue biopsy or as a complement to biomarkers in assessing and classifying BC. As such, in this review, the potential of miRNAs as the key BC signatures in liquid biopsy are addressed, including the role of artificial intelligence (AI) and machine learning platforms (ML), in capitalizing on the big data of miRNA for a more comprehensive assessment of the cancer, leading to practical clinical utility in BC management.

1 November 2020 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
ZCZhi Xiong Chong
Zhi Xiong Chong
SYSwee Keong Yeap
Swee Keong Yeap
WHWan Yong Ho
Wan Yong Ho

Verified
Journal Article
Open access
PDF file
AAAhmed Faris Aldoghachi
Ahmed Faris Aldoghachi
ZCZhi Xiong Chong
Zhi Xiong Chong
SYSwee Keong Yeap
Swee Keong Yeap
SCSoon Keng Cheong
Soon Keng Cheong
WHWan Yong Ho
Wan Yong Ho
HOHan Kiat Ong
Han Kiat Ong
Cancer recurrence and drug resistance following treatment, as well as metastatic forms of cancer, are trends that are commonly encountered in cancer management. Amidst the growing popularity of personalized medicine and targeted therapy as effective cancer treatment, studies involving the use of stem cells in cancer therapy are gaining ground as promising translational treatment options that are actively pursued by researchers due to their unique tumor-homing activities and anti-cancer properties. Therefore, this review will highlight cancer interactions with commonly studied stem cell types, namely, mesenchymal stroma/stem cells (MSC), induced pluripotent stem cells (iPSC), iPSC-derived MSC (iMSC), and cancer stem cells (CSC). A particular focus will be on the effects of paracrine signaling activities and exosomal miRNA interaction released by MSC and iMSCs within the tumor microenvironment (TME) along with their therapeutic potential as anti-cancer delivery agents. Similarly, the role of exosomal miRNA released by CSCs will be further discussed in the context of its role in cancer recurrence and metastatic spread, which leads to a better understanding of how such exosomal miRNA could be used as potential forms of non-cell-based cancer therapy.